4.6 Article

Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Dclk1 distinguishes between tumor and normal stem cells in the intestine

Yuki Nakanishi et al.

NATURE GENETICS (2013)

Article Gastroenterology & Hepatology

DCLK I immunoreactivity in colorectal neoplasia

Giuseppe Gagliardi et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2012)

Review Biochemistry & Molecular Biology

Vimentin in cancer and its potential as a molecular target for cancer therapy

Arun Satelli et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2011)

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Biotechnology & Applied Microbiology

Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism

Sripathi M. Sureban et al.

JOURNAL OF NANOBIOTECHNOLOGY (2011)

Article Medicine, General & Internal

Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.

Makoto Maemondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Selective Blockade of DCAMKL-1 Results in Tumor Growth Arrest by a Let-7a MicroRNA-Dependent Mechanism

Sripathi M. Sureban et al.

GASTROENTEROLOGY (2009)

Review Biochemistry & Molecular Biology

Tumor microenvironment and angiogenesis

Pia Nyberg et al.

FRONTIERS IN BIOSCIENCE (2008)

Review Oncology

Epithelial-mesenchymal transitions in tumour progression

JP Thiery

NATURE REVIEWS CANCER (2002)